|
|
|
Bioscience Valuation, a Leader in Evidence-Based Evaluations
Bioscience Valuation provides evidence-based value, commercial, R&D, and economic assessments to pharmaceutical and biotechnology companies. These assessments support investment and partnering decisions.
Each analysis covers the entire spectrum of commercial, R&D and financial variables. Our appraisals are based on Bioscience Valuation's profound subject expertise and long-standing experience, and are backed by comprehensive research taking advantage of Bioscience Valuation's extensive databases.
Pharmaceutical companies use our services to
- Determine project value and support portfolio management decisions
- Assess in-licensing candidates and potential M&A transactions
- Forecast a drug's sales potential (primary and secondary market research, pharmacoeconomics)
- Increase R&D productivity
- Optimize resource planning and capacity utilization
Biotech companies use our services to
- Identify licensing partners, optimize term sheets and negotiate value-maximizing agreements
- Prepare funding rounds and attract investors
Healthcare companies and organizations use our services to
- Assess the economic impact of healthcare policies
- Facilitate healthcare policy decisions
Investors use our services to
- Facilitate investment decisions
- Support their due diligence efforts
|
|
|
